Earlier relapse detection after allogeneic haematopoietic stem cell transplantation by chimerism assays: Digital PCR versus quantitative real-time PCR of insertion/deletion polymorphisms

PloS One
Jennifer Valero-GarciaA Jiménez-Velasco

Abstract

The analysis of molecular haematopoietic chimerisms (HC) has become a well-established method to monitor the transplant evolution and to assess the risk of relapse after allogeneic stem cells transplantation (allo-STC). Different techniques and molecular markers are being used for chimerism surveillance after transplantation, including quantitative real-time PCR (qPCR) and the recently developed digital PCR (dPCR). This study aims to compare the sensitivity and accuracy of both methods to quantify HC and predict early relapse. HC was evaluated using custom PCR systems for the specific detection of the Y-chromosome, null alleles and insertion-deletion polymorphisms. A total of 281 samples from 28 adult patients who underwent an allo-SCT were studied. Increasing mixed chimerism was detected prior to relapse in 100% of patients (18 relapses). Compared with conventional qPCR amplification, dPCR predicted relapse with a median anticipation period of 63 days versus 45.5 days by qPCR. Overall, 56% of the relapses were predicted earlier with dPCR whereas 38% of the relapses where detected simultaneously using both techniques and only in 1 case, relapse was predicted earlier with qPCR. In conclusion, chimerism determination by dPCR cons...Continue Reading

References

Jun 4, 2004·American Journal of Pharmacogenomics : Genomics-related Research in Drug Development and Clinical Practice·Christian Thiede
Mar 21, 2007·Basic Research in Cardiology·Mariëlle C Hendriks-BalkAstrid E Alewijnse
Oct 9, 2013·Clinical Chemistry·Jim F Huggett, Alexandra Whale
Oct 24, 2014·Clinical Chemistry·Jim F HuggettCarole A Foy
Mar 22, 2015·Experimental Hematology·Tanja StahlBoris Fehse
May 12, 2015·Transfusion Medicine and Hemotherapy : Offizielles Organ Der Deutschen Gesellschaft Fur̈ Transfusionsmedizin Und Immunham̈atologie·Christian BachBernd M Spriewald
Mar 17, 2017·Journal of Clinical Microbiology·Jane Kuypers, Keith R Jerome
Apr 28, 2017·International Journal of Laboratory Hematology·N M CruzM L Guzman
Aug 31, 2017·Scientific Reports·Nivedita MajumdarPatricia Hegerich
Nov 14, 2017·Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology·Yu TongZhi Chen
Apr 20, 2018·Journal of Clinical Immunology·Tsubasa OkanoTomohiro Morio

❮ Previous
Next ❯

Citations

May 10, 2019·International Journal of Molecular Sciences·Daniela CilloniGiuseppe Saglio
Feb 7, 2020·Bone Marrow Transplantation·Joaquim VivesNúria Nogués
Jan 28, 2022·Bone Marrow Transplantation·Amanda G Blouin, Medhat Askar

❮ Previous
Next ❯

Methods Mentioned

BETA
PCR
FACS
genotyping
chip
flow cytometry

Software Mentioned

QuantStudio 3D AnalysisSuite Cloud
QuantStudio

Related Concepts

Related Feeds

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.